Godrej Agrovet Ltd
Godrej Agrovet Q3 FY25: Capex ₹161 Cr
Q3 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Astec CDMO business is expected to see 30-35% growth in FY26 with confirmed orders, though FY25 was flat due to order postponements. Animal Feed segment expects sustained EBIT per ton of ₹1,800 to ₹2,000 in FY26, backed by R&D and cost initiatives.
From Godrej Agrovet Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Astec CDMO business is expected to see 30-35% growth in FY26 with confirmed orders, though FY25 was flat due to order postponements.
- Enterprise business volume growth is cautiously expected at 14-16% in FY26 with a focus on positive contribution margins.
- Animal Feed EBIT per ton is expected to remain sustainable at ₹1,800-2,000 in FY26, supported by R&D and cost initiatives.
- Dairy segment showed 1.7% revenue growth in first nine months FY25 with an expected improvement in Q4 fueled by the season and price increases.
- Palm Oil division had strong performance due to favorable external factors, with potential for continuation but also affected by global factors.
- Crop protection segments experience volume fluctuations; focus on cotton herbicide expected to show good numbers.
2 more points from Godrej Agrovet Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Godrej Agrovet Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Godrej Agrovet has done ₹161 crores of CAPEX consolidated in the first nine months of FY25.
- They expect to end FY25 with about ₹220 crores of CAPEX.
- A similar CAPEX plan is in place for FY26.
- In pet food, the pilot plant will be ready in a few weeks for R&D and marketing trials.
- The full-scale pet food plant (35,000 to 40,000 tons per annum) is expected by end of FY26.
2 more points from Godrej Agrovet Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Godrej Agrovet Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Astec LifeSciences' CDMO business currently has confirmed orders/orders backed by purchase orders (POs).
- Visibility for FY26 CDMO growth is around 30% to 35%, with potential to reach 40%, pending one or two customer confirmations.
- Management emphasized reliance only on confirmed orders for forecasts due to postponements or cancellations in bad times.
- FY25 CDMO growth expected to be flat (no growth) due to market inventory buildup and delays.
2 more points from Godrej Agrovet Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Godrej Agrovet Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.3K Cr, net profit ₹102 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Godrej Agrovet Ltd's management said in earlier quarters
Others in Food Products this season
- Sharat Industrie (Q3 FY25)
Revenue: ₹96.45 Crores, up 58.8% Year-on-Year (YoY) . Key concall takeaways from Sharat Industries Ltd's Q3 FY25 earnings call — and how it ranks against…
- Apex Frozen Foods Ltd (Q3 FY25)
Capacity utilization currently at ~35%, with potential to improve if supply stabilizes. Key concall takeaways from Apex Frozen Foods Ltd's Q3 FY25 earnings…
- Zydus Wellness Ltd (Q3 FY25)
Digital channel (e-commerce) now contributes about 10%-11% of revenue and growing faster than other segments. Key concall takeaways from Zydus Wellness Ltd's…
- Gopal Snacks Ltd (Q3 FY25)
1,800 crores in FY26. Key concall takeaways from Gopal Snacks Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Godrej Agrovet Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Godrej Agrovet Ltd Q3 FY25 results?
Astec CDMO business is expected to see 30-35% growth in FY26 with confirmed orders, though FY25 was flat due to order postponements. Animal Feed segment expects sustained EBIT per ton of ₹1,800 to ₹2,000 in FY26, backed by R&D and cost initiatives.
What is Godrej Agrovet Ltd share price analysis?
Godrej Agrovet Ltd currently shows a neutral. The stock trades at a P/E of 23.8 with a market cap of ₹11,166 Cr. Investors should review the full earnings analysis for detailed insights.
Is Godrej Agrovet Ltd planning capital expenditure?
Godrej Agrovet has done ₹161 crores of CAPEX consolidated in the first nine months of FY25.
Keep Godrej Agrovet Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.